Respiratory Syncytial Virus (RSV) is a highly contagious virus that can cause respiratory infections ranging from a simple upper respiratory tract infection (like the common cold) to pneumonia.
Protecting the elderly
RSV can be severe, especially in the elderly and/or those with chronic illnesses such as heart disease (e.g., congestive heart failure) or lung disease (such as COPD or asthma).
The lack of a cure
RSV can worsen these chronic illnesses, potentially requiring hospitalization in intensive care and even leading to death. Currently, there is no specific cure for this infection.
Reducing the number of infections
The French National Authority for Health (HAS) recommends seasonal RSV vaccination for individuals aged 75 and over to reduce the number of acute lower respiratory tract infections related to RSV.
Vaccination for protection
Furthermore, the HAS recommends vaccination for individuals aged 65 and over with chronic respiratory conditions (particularly COPD) or cardiac conditions (particularly heart failure) that could worsen during an RSV infection. In addition, acceptability surveys regarding RSV vaccination in adults, conducted both in France and abroad, report a majority of positive opinions regarding vaccination.
 Didier Galibert
|
01/10/2024 | 
| 
Anglais
Arabic
Deutsch
Français
Español
Italien
Português
Russian